Research progress of interventional therapy of colorectal liver metastasis

doi:10.3877/cma.j.issn.2095-2015.2024.02.015

Abstract

Abstract:

Liver metastasis is the main cause of death in patients with colorectal cancer. Surgical resection is the most effective treatment for colorectal liver metastasis (CRLM), but radical surgical resection is not possible in most patients. In recent years, with the continuous development of interventional techniques, interventional therapy has significant effects on local control and overall survival of patients with CRLM, and has become an important means of individual treatment and multidisciplinary team treatment of CRLM. This article mainly reviews the latest research and development trend of interventional therapy for CRLM.

Key words: Colorectal cancer, Liver metastasis, Transcatheter arterial chemoembolization, Endoscopic chemical ablation

Pengwei Zhang, Chaofeng Yang, Yang Li. Research progress of interventional therapy of colorectal liver metastasis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(02): 177-182.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2024.02.015

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2024/V14/I02/177

References 36

[1]	Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(3): 233-254.
[2]	Mauri G, Monfardini L, Garnero A, et al. Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin[J]. Cancers, 2021, 13(11): 2617.
[3]	中国医师协会外科医师分会, 中华医学会外科分会胃肠外科学组, 中华医学会外科分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J]. 中国普通外科杂志, 2023, 22(1): 1-29.
[4]	Hasselgren K, Røsok BI, Larsen PN, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM[J]. Ann Surg, 2021, 273(3): 442-448.
[5]	Chebaro A, Buc E, Durin T, et al. Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy?[J]. Ann Surg, 2021, 274(5): 874-880.
[6]	Laurent C, Fernandez B, Marichez A, et al. Radiological Simultaneous Portohepatic Vein Embolization(RASPE) Before Major Hepatectomy[J]. Ann Surg, 2020, 272(2): 199-205.
[7]	彭淑牖, 黄从云, 李江涛, 等. 末梢门静脉栓塞术在计划性肝切除术中的应用初探[J]. 中华外科杂志, 2016, 54(9): 664-668.
[8]	彭淑牖, 黄从云, 王许安, 等. 末梢门静脉栓塞技术在余肝体积不足肝细胞癌中的应用价值[J]. 中华外科杂志, 2021, 59(10): 829-835.
[9]	Walker BS, Billingsley KG, Sutton TL, et al. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program[J]. J Surg Oncol, 2022, 126(3): 513-522.
[10]	Zhang Y, Wang K, Yang T, et al. Meta-Analysis of Hepatic Arterial Infusion for Liver Metastases From Colorectal Cancer[J]. Front Oncol, 2021, 11: 628558.
[11]	Datta J, Narayan RR, Kemeny NE, et al. Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review[J]. JAMA Surg, 2019, 154(8): 768.
[12]	Koerkamp BG, Sadot E, Kemeny NE, et al. Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.[J]. J Clin Oncol, 2017(17): 1938-1944.
[13]	Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update[J]. J Hepatol, 2022, 76(3): 681-693.
[14]	Gruber Rouh T, Naguib NNN, Eichler K, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: Long-term results over a 10-year period[J]. Int J Cancer, 2014, 134(5): 1225-1231.
[15]	Vogl TJ, Lahrsow M, Albrecht MH, et al. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization(cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation[J]. Eur J Radiol, 2018, 102: 138-145.
[16]	Chen S, Yang Y, Jiao Y, et al. Efficacy of Drug-Eluting Bead Transarterial Chemoembolization in the Treatment of Colorectal Cancer Liver Metastasis[J]. J Healthc Eng, 2022, 2022: 1-5.
[17]	Fiorentini G, Aliberti C, Tilli M, et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads(DEBIRI) versus intravenous therapy(FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study[J]. Anticancer Res, 2012, 32(4): 1387-1395.
[18]	Zhao G, Liu S, Zhang Y, et al. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases[J]. Irish J Med Sci, 2022, 191(3): 1139-1145.
[19]	高洁, 刘晓明, 周文华, 等. 90Y微球的研发现状与应用研究[J]. 同位素, 2022, 35(3): 189-199.
[20]	Ehrhardt GJ, Day DE. Therapeutic use of 90Y microspheres. Nuel Med Biol, 1987, 3(14): 233-242.
[21]	Chua TC, Bester L, Saxena A, et al. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases[J]. J Cancer Res Clin Oncol, 2011, 137(5): 865-873.
[22]	Entezari P, Gabr A, Salem R, et al. Yttrium-90 for colorectal liver metastasis-the promising role of radiation segmentectomy as an alternative local cure[J]. Int J Hyperthermia, 2022: 39(1): 620-626.
[23]	Raphael MJ, Karanicolas PJ. Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?[J]. J Clin Oncol, 2022, 40(24): 2806-2817.
[24]	Ruers T, Van Coevorden F, Punt CJA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial[J]. J Natl Cancer Inst, 2017, 109(9): djx015.
[25]	肖永胜, 郭磊, 叶青海. 结直肠癌肝转移外科治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2019(4): 294-296.
[26]	Lubner MG, Brace CL, Hinshaw JL, et al. Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices[J]. J Vasc Intervent Radiol, 2010, 21(8): S192-S203.
[27]	Huang Z, Pan Y, Zhou P, et al. Long-term outcomes of ultrasound-guided percutaneous microwave ablation versus resection for colorectal cancer liver metastases: a propensity-score matched study[J]. Int J Hyperthermia, 2021, 38(1): 1276-1284.
[28]	Shi Y, Wang Z, Chi J, et al. Long-term results of percutaneous microwave ablation for colorectal liver metastases[J]. HPB, 2021, 23(1): 37-45.
[29]	Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis[J]. Eur Radiol, 2018, 28(8): 3228-3236.
[30]	Mahnken AH, König AM, Figiel JH. Current Technique and Application of Percutaneous Cryotherapy Aktuelle Technik und Anwendung der perkutanen Kryotherapie[J]. Rofo, 2018, 190(9): 836-846.
[31]	Xu KC, Niu LZ, He WB, et al. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases[J]. World J Gastroenterol, 2008, 14(9): 1430-1436.
[32]	Pusceddu C, Mascia L, Ninniri C, et al. The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report[J]. Cancers, 2022, 14(12): 3018.
[33]	Belfiore MP, De Chiara M, Reginelli A, et al. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it[J]. Front Oncol, 2022, 12: 943176.
[34]	Koethe Y, Wilson N, Narayanan G. Irreversible electroporation for colorectal cancer liver metastasis: a review[J]. Int J Hyperthermia, 2022, 39(1): 682-687.
[35]	Zhang X, Zhang X, Ding X, et al. Novel irreversible electroporation ablation(Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study[J]. Front Oncol, 2022, 12: 945123.
[36]	Hosein PJ, Echenique A, Loaiza-Bonilla A, et al. Percutaneous Irreversible Electroporation for the Treatment of Colorectal Cancer Liver Metastases with a Proposal for a New Response Evaluation System[J]. J Vasc Interv Radiol, 2014, 25(8): 1233-1239.

Please choose a citation manager

Content to export